• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A systematic review of the safety of non-tumour necrosis factor inhibitor and targeted synthetic drugs in rheumatic disease in pregnancy.

作者信息

Ahmed Kawser, Giles Ian, Nguyen Hanh, Flint Julia

机构信息

UCL Medical School, London, UK.

University College London Hospitals NHS Foundation Trust, London, UK.

出版信息

Clin Med (Lond). 2020 Mar;20(Suppl 2):s98. doi: 10.7861/clinmed.20-2-s98.

DOI:10.7861/clinmed.20-2-s98
PMID:32409405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7243518/
Abstract
摘要

相似文献

1
A systematic review of the safety of non-tumour necrosis factor inhibitor and targeted synthetic drugs in rheumatic disease in pregnancy.非肿瘤坏死因子抑制剂和靶向合成药物在妊娠期风湿性疾病中安全性的系统评价。
Clin Med (Lond). 2020 Mar;20(Suppl 2):s98. doi: 10.7861/clinmed.20-2-s98.
2
A Systematic Review of the safety of non-TNF inhibitor biologic and targeted synthetic drugs in rheumatic disease in pregnancy.风湿性疾病妊娠患者中，非 TNF 抑制剂生物制剂和靶向合成药物安全性的系统评价
Semin Arthritis Rheum. 2021 Dec;51(6):1205-1217. doi: 10.1016/j.semarthrit.2021.09.004. Epub 2021 Sep 16.
3
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs.一大群接受生物和靶向合成抗风湿药物治疗的患者中的新冠肺炎肺炎
Ann Rheum Dis. 2021 Feb;80(2):e14. doi: 10.1136/annrheumdis-2020-217681. Epub 2020 May 15.
4
[Rheumatic diseases need more attention in case of the desire to have children and during pregnancy].在有生育意愿及孕期时，风湿性疾病需要更多关注。
Ned Tijdschr Geneeskd. 2011;155(13):A2622.
5
Prevalence of COVID-19 among patients with rheumatic diseases: the need to await results from large collaborative studies. Response to: 'COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs' by Conticini .风湿性疾病患者中新型冠状病毒肺炎（COVID-19）的患病率：需要等待大型合作研究的结果。对Conticini所著《一大群接受生物和靶向合成抗风湿药物治疗的患者中的COVID-19肺炎》的回应
Ann Rheum Dis. 2021 Feb;80(2):e15. doi: 10.1136/annrheumdis-2020-217738. Epub 2020 May 15.
6
Was risk properly assessed in Carter, et al's safety assessment of tumor necrosis factor antagonists during pregnancy?在卡特等人对肿瘤坏死因子拮抗剂孕期安全性的评估中，风险是否得到了恰当评估？
J Rheumatol. 2009 Sep;36(9):2122; author reply 2123. doi: 10.3899/jrheum.090141.
7
[Pregnancy in rheumatic patients treated with biologic drugs].[接受生物药物治疗的风湿性疾病患者的妊娠情况]
Lijec Vjesn. 2010 Sep-Oct;132(9-10):317-8.
8
Introduction.引言。
Expert Opin Drug Saf. 2016 Dec;15(sup1):1. doi: 10.1080/14740338.2016.1240784.
9
Update in rheumatology: evidence published in 2011.风湿病学进展：2011年发表的证据
Ann Intern Med. 2012 Jul 17;157(2):114-9. doi: 10.7326/0003-4819-157-2-201204030-00408.
10
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.EULAR 关于在妊娠前、妊娠期间和哺乳期使用抗风湿药物的注意事项。
Ann Rheum Dis. 2016 May;75(5):795-810. doi: 10.1136/annrheumdis-2015-208840. Epub 2016 Feb 17.

引用本文的文献

1
The Influence of Treatment of Inflammatory Arthritis During Pregnancy on the Long-Term Children's Outcome.孕期炎症性关节炎的治疗对儿童远期结局的影响
Front Pharmacol. 2021 Mar 18;12:626258. doi: 10.3389/fphar.2021.626258. eCollection 2021.
2
Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review.孕期炎性小体靶向治疗：来自FAERS数据库真实世界数据分析及系统评价的新见解
Front Pharmacol. 2021 Jan 20;11:612259. doi: 10.3389/fphar.2020.612259. eCollection 2020.